Clinico-Epidemiological Characteristics of Hidradenitis Suppurativa
Open Access
- 1 July 2021
- journal article
- research article
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 12 (4) , 561-565
Abstract
Background: Hidradenitis suppurativa (HS) is a chronic debilitating disease with a relapsing and remitting course. Due to delay in diagnosis, patients are often referred when the disease is very severe. Management strategies vary across multiple guidelines. Aims: The aim of this study was to analyze the demographic and clinical characteristics of patients with HS among our outpatient attendees and to study the outcomes of various treatments offered. Methodology: This was a retrospective cohort study analyzing case files and photographic records of all patients diagnosed with HS, presenting to our tertiary care institute over 18 months. Results: A total of 22 patients (10 males and 12 females) of HS were studied with majority having Hurley stage 2 and 3 diseases. The most common site affected was axilla. Overweight and obese patients were 45.4% and 18.1%, respectively. Rifampicin–clindamycin combination or doxycycline was the first line therapy offered. Adalimumab was given in only two patients but could not be continued for long term due to financial issues. Surgery was performed in six patients. Procedures included wide local excision and deroofing which is left to heal by secondary intention. Least number of remissions and most satisfactory improvement was seen with a combination of antibiotics and surgery compared to medical treatment alone. Limitations: Retrospective nature and a single center study were the major drawbacks. Conclusion: Patients undergoing procedural intervention in addition to pharmacotherapy have best overall outcomes and involvement of a multidisciplinary team plays a key role, however a larger follow-up study is required.Keywords
This publication has 14 references indexed in Scilit:
- North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa FoundationsJournal of the American Academy of Dermatology, 2019
- Hidradenitis Suppurativa Is Associated with Polycystic Ovary Syndrome: A Population-Based Analysis in the United StatesJournal of Investigative Dermatology, 2018
- Quality of life and sexual health in patients with hidradenitis suppurativaInternational Journal of Women's Dermatology, 2018
- Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne InversaDermatology, 2017
- Comorbidities, treatment, and outcome in severe anogenital inverse acne (hidradenitis suppurativa): a 15-year single center reportInternational Journal of Dermatology, 2016
- South Italy: A Privileged Perspective to Understand the Relationship between Hidradenitis Suppurativa and Overweight/ObesitySkin Appendage Disorders, 2016
- Diagnostic delay in hidradenitis suppurativa is a global problemBritish Journal of Dermatology, 2015
- Hidradenitis suppurativa and metabolic syndrome: a comparative cross‐sectional study of 3207 patientsBritish Journal of Dermatology, 2015
- European S1 guideline for the treatment of hidradenitis suppurativa/acne inversaJournal of the European Academy of Dermatology and Venereology, 2015
- The natural history of hidradenitis suppurativaJournal of the European Academy of Dermatology and Venereology, 2000